Longitudinal profiling reveals a persistent intestinal dysbiosis triggered by conventional anti-tuberculosis therapy/Experiment 19/Signature 2
From BugSigDB
Needs review
Source: Additional file 11: Figure S11
Description: Differentially abundant between the Naive group and Pyrazinamide treatment group.
Abundance in Group 1: decreased abundance in Z (Pyrazinamide)
| NCBI | Quality Control | Links |
|---|---|---|
| Thomasclavelia | ||
| Sporobacter | ||
| Arthrobacter | ||
| Akkermansia |
Revision editor(s): KateRasheed
